Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 20Carcinoma, Squamous Cell 4Neoplasms 3Adenocarcinoma 3Radiation Injuries 2Stomach Neoplasms 1Sarcopenia 1Respiratory Insufficiency 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Pulmonary Fibrosis 1Pneumonia 1Obesity, Abdominal 1Obesity 1Neoplastic Cells, Circulating 1National Cancer Center/Cancer Hospital 1Motor Activity 1Lymphatic Metastasis 1Esophageal Diseases 1Anastomotic Leak 1

Interventions

Blood Specimen Collection 13Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Surgical Procedures, Operative 3Pirinitramide 2Morphine 2Bevacizumab 2ribociclib 1lanreotide 1jinfukang 1eribulin 1cabazitaxel 1Zoledronic Acid 1Vinorelbine 1Trastuzumab 1Thiotepa 1Taxes 1Stem Cell Transplantation 1Standard of Care 1Spinal Puncture 1Sorafenib 1Radiofrequency Ablation 1Propofol 1Pemetrexed 1Octreotide 1Letrozole 1Lapatinib 1Injections, Epidural 1Injections 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplastic Cells, Circulating × Esophagectomy × Clear all
NCT01858805 2014-11-18

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer

Universitätsklinikum Hamburg-Eppendorf

Completed
123 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡